Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.52 |
| ▸ | CA6 | P23280 | 5/20 | 0.52 |
| ▸ | CA7 | P43166 | 5/20 | 0.52 |
| ▸ | CA9 | Q16790 | 5/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.52 |
| ▸ | CA2 | P00918 | 4/20 | 0.52 |
| ▸ | CA4 | P22748 | 4/20 | 0.52 |
| ▸ | CA5A | P35218 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | CASP2 | P42575 | 2/20 | 0.52 |
| ▸ | F13A1 | P00488 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | THPO | P40225 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norspermidine SCHEMBL1741553 | 0.95 | CA12 (0.52) | CA12CA6CA7CA9CA14 | |
| SCHEMBL22166080 | 0.86 | CA12 (0.59) | CA12CA6CA7CA9CA14 | |
| SCHEMBL2107512 | 0.84 | CA12 (0.50) | CA12CA6CA7CA9CA14 | |
| SCHEMBL24967862 | 0.84 | CA12 (0.46) | CA12CA6CA7CA9CA14 | |
| SCHEMBL31091970 | 0.84 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL2353027 | 0.84 | CA12 (0.50) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18405505 | 0.82 | CYP2C19 (0.46) | CA12CA6CA7CA9CA14 | |
| SCHEMBL19780932 | 0.81 | CA12 (0.46) | CA12CA6CA7CA9CA14 | |
| SCHEMBL12335787 | 0.81 | CA12 (0.57) | CA12CA6CA7CA9CA14 | |
| SCHEMBL22186 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522689-B2 | Mannich base epoxy curative, cured epoxy resins thereof and methods of preparing the same | JONES PAUL (GB) | 2026-01-13 | — | — | US | claimed |
| EP-4251672-B1 | POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE | JONES PAUL (GB) | 2025-09-24 | — | — | EP | claimed |
| US-20240026067-A1 | POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE | JONES PAUL (GB) | 2024-01-25 | — | — | US | claimed |
| WO-2023233151-A1 | PROCESS FOR PREPARING BIO-BASED CURED EPOXY RESIN, AND BIO-BASED RESINS OBTAINABLE THEREFROM | JONES PAUL (GB) | 2023-12-07 | — | — | WO | claimed |
| US-20230357489-A1 | MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME | JONES PAUL (GB) | 2023-11-09 | — | — | US | claimed |
| EP-4251672-A1 | POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE | Jones, Paul (GB) | 2023-10-04 | — | — | EP | claimed |
| EP-4097164-B1 | MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME | JONES PAUL (GB) | 2023-08-23 | — | — | EP | claimed |
| EP-4097164-A1 | MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME | Jones, Paul (GB) | 2022-12-07 | — | — | EP | claimed |
| WO-2022112776-A1 | POLYMERIC MANNICH BASE, PREPARATION METHODS AND USE AS AN EPOXY RESIN CURATIVE | JONES PAUL (GB) | 2022-06-02 | — | — | WO | claimed |
| WO-2021152281-A1 | MANNICH BASE EPOXY CURATIVE, CURED EPOXY RESINS THEREOF AND METHODS OF PREPARING THE SAME | JONES PAUL (GB) | 2021-08-05 | — | — | WO | claimed |
| US-20260139118-A1 | METHOD FOR THE DEGRADATION OF EPOXY HYBRID RESIN | EVONIK OPERATIONS GMBH (DE) | 2026-05-21 | — | — | US | disclosed |
| EP-4745185-A1 | METHOD FOR DEGRADING EPOXY HYBRID RESIN | Evonik Operations GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| CN-122060216-A | Degradation method of epoxy hybrid resin | 赢创运营有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260125584-A1 | TWO-COMPONENT EPOXY ADHESIVE FOR LIQUIFIED NATURAL GAS CONTAINERS | SIKA TECHNOLOGY AG (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-4737500-A1 | RAPID CURE EPOXY RESIN HARDENERS | Jones, Paul (GB) | 2026-05-06 | — | — | EP | disclosed |
| WO-2007036572-A1 | COMPOUNDS CONTAINING ALDIMINE | SIKA TECHNOLOGY AG (CH) | 2007-04-05 | — | — | WO | disclosed |
| WO-2007036575-A1 | REACTIVE POLYURETHANE-HOT MELT ADHESIVE HAVING A LOW ISOCYANATE-MONOMER CONTENT | SIKA TECHNOLOGY AG (CH) | 2007-04-05 | — | — | WO | disclosed |
| WO-2007036574-A1 | MOISTURE-HARDENED POLYURETHANE COMPOSITIONS CONTAINING COMPOUNDS COMPRISING ALDIMINE | SIKA TECHNOLOGY AG (CH) | 2007-04-05 | — | — | WO | disclosed |
| WO-2007036571-A1 | ALDIMINES COMPRISING REACTIVE GROUPS CONTAINING ACTIVE HYDROGEN, AND USE THEREOF | SIKA TECHNOLOGY AG (CH) | 2007-04-05 | — | — | WO | disclosed |
| EP-1770107-A1 | Polyurethane composition curable by humidity | Sika Technology AG (CH) | 2007-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139118-A1 | METHOD FOR THE DEGRADATION OF EPOXY HYBRID RESIN | RPS20, RPS10, SMARCC2 | CA12 1741/4885CA6 3375/4885CA7 2363/4885 |
| US-20260125584-A1 | TWO-COMPONENT EPOXY ADHESIVE FOR LIQUIFIED NATURAL GAS CONTAINERS | PTGER2, SETDB1, ITGA2 | CA12 1108/4885CA6 3177/4885CA7 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.